- This event has passed.
Breakthrough or Breakdown: Should the FDA Have Approved the New Alzheimer’s Drug?
July 12, 2021 @ 10:00 am EDT
Hastings Center President Mildred Z. Solomon will be hosting our next Hastings Conversations webinar as she will get to the bottom of the FDA’s decision and its consequences for patients and families, the health care system, and the integrity of regulatory oversight.
